• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卢旺达对 Duffy 阳性患者的间日疟原虫疟疾。

Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda.

机构信息

Institute of International Health, Center for Global Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.

John Curtin School of Medical Research, Australian National University, Canberra, Australia.

出版信息

Am J Trop Med Hyg. 2023 Aug 7;109(3):621-623. doi: 10.4269/ajtmh.23-0143. Print 2023 Sep 6.

DOI:10.4269/ajtmh.23-0143
PMID:37549894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10484245/
Abstract

Plasmodium vivax is the second-most common malaria pathogen globally, but is considered very rare in the predominantly Duffy-negative sub-Saharan African population. In 259 malaria patients from highland southern Rwanda, we assessed Plasmodium species and Duffy blood group status by polymerase chain reaction (PCR). Plasmodium falciparum, P. vivax, Plasmodium malariae, and Plasmodium ovale were seen in 90.7%, 8.1%, 11.6%, and 5.0%, respectively. Plasmodium vivax occurred more frequently as a monoinfection than in combination with P. falciparum. All P. vivax-infected individuals showed heterozygous Duffy positivity, whereas this was the case for only 3.1% of patients with P. falciparum monoinfection and malaria-negative control subjects (P < 0.01). Based on PCR diagnosis, P. vivax is not rare in southern Rwanda. All episodes of P. vivax were observed in heterozygous Duffy-positive patients, whereas elsewhere in Africa, P. vivax is also reported in Duffy-negative individuals. Refined mapping of Plasmodium species is required to establish control and elimination strategies including all malaria species.

摘要

间日疟原虫是全球第二常见的疟原虫病原体,但在主要为 Duffy 阴性的撒哈拉以南非洲人群中被认为非常罕见。在卢旺达南部高地的 259 名疟疾患者中,我们通过聚合酶链反应 (PCR) 评估了疟原虫种类和 Duffy 血型状况。分别在 90.7%、8.1%、11.6%和 5.0%的患者中观察到恶性疟原虫、间日疟原虫、卵形疟原虫和三日疟原虫。间日疟原虫更常以单一感染的形式出现,而不是与恶性疟原虫混合感染。所有感染间日疟原虫的个体均表现为杂合 Duffy 阳性,而单纯感染恶性疟原虫的患者和疟疾阴性对照者中仅 3.1%为这种情况(P < 0.01)。基于 PCR 诊断,间日疟原虫在卢旺达南部并不罕见。所有间日疟原虫感染均发生在杂合 Duffy 阳性患者中,而在非洲其他地区,也有报道称 Duffy 阴性个体也感染间日疟原虫。需要进行更精细的疟原虫种类绘图,以制定包括所有疟原虫在内的控制和消除策略。

相似文献

1
Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda.卢旺达对 Duffy 阳性患者的间日疟原虫疟疾。
Am J Trop Med Hyg. 2023 Aug 7;109(3):621-623. doi: 10.4269/ajtmh.23-0143. Print 2023 Sep 6.
2
Detection of Duffy blood group genotypes and submicroscopic Plasmodium infections using molecular diagnostic assays in febrile malaria patients.采用分子诊断检测技术在发热性疟疾患者中检测达菲血型基因型和亚微观疟原虫感染。
Malar J. 2024 Jun 20;23(1):194. doi: 10.1186/s12936-024-04875-5.
3
Molecular identification of Plasmodium species responsible for malaria reveals Plasmodium vivax isolates in Duffy negative individuals from southwestern Nigeria.分子鉴定导致疟疾的疟原虫种类显示,来自尼日利亚西南部的 Duffy 阴性个体中存在间日疟原虫分离株。
Malar J. 2018 Nov 28;17(1):439. doi: 10.1186/s12936-018-2588-7.
4
Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia.埃塞俄比亚达菲阳性和达菲阴性人群中间日疟原虫和恶性疟原虫疟疾的分子流行病学
Malar J. 2015 Feb 19;14:84. doi: 10.1186/s12936-015-0596-4.
5
Plasmodium vivax infection in Anajás, State of Pará: no differential resistance profile among Duffy-negative and Duffy-positive individuals.巴西北部帕拉州阿纳亚斯的间日疟原虫感染:杜菲阴性和杜菲阳性个体之间无差异耐药性特征。
Malar J. 2012 Dec 22;11:430. doi: 10.1186/1475-2875-11-430.
6
Presence of additional Plasmodium vivax malaria in Duffy negative individuals from Southwestern Nigeria.来自尼日利亚西南部的 Duffy 阴性个体中存在额外的间日疟原虫疟疾。
Malar J. 2020 Jun 26;19(1):229. doi: 10.1186/s12936-020-03301-w.
7
High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana.在加纳,Duffy 阴性基因型的高频出现和不存在间日疟原虫感染。
Malar J. 2021 Feb 17;20(1):99. doi: 10.1186/s12936-021-03618-0.
8
Infections in Duffy-Negative Individuals in the Democratic Republic of the Congo.刚果民主共和国内缺乏趋化因子受体 Duffy 阴性个体的感染情况。
Am J Trop Med Hyg. 2018 Nov;99(5):1128-1133. doi: 10.4269/ajtmh.18-0277.
9
Re-evaluation of microscopy confirmed Plasmodium falciparum and Plasmodium vivax malaria by nested PCR detection in southern Ethiopia.通过巢式PCR检测对埃塞俄比亚南部经显微镜检查确诊的恶性疟原虫和间日疟原虫疟疾进行重新评估。
Malar J. 2014 Feb 6;13:48. doi: 10.1186/1475-2875-13-48.
10
Molecular evidence of high rates of asymptomatic P. vivax infection and very low P. falciparum malaria in Botswana.博茨瓦纳间日疟原虫无症状感染率高和恶性疟原虫疟疾发病率极低的分子证据。
BMC Infect Dis. 2016 Sep 29;16(1):520. doi: 10.1186/s12879-016-1857-8.

引用本文的文献

1
Prevalence of asymptomatic non-falciparum and falciparum malaria in the 2014-15 Rwanda Demographic Health Survey.2014 - 15年卢旺达人口与健康调查中无症状非恶性疟和恶性疟的患病率。
PLoS One. 2025 Sep 11;20(9):e0330480. doi: 10.1371/journal.pone.0330480. eCollection 2025.
2
Prevalence of Asymptomatic non-Falciparum and Falciparum Malaria in the 2014-15 Rwanda Demographic Health Survey.2014 - 15年卢旺达人口与健康调查中无症状非恶性疟和恶性疟的流行情况
medRxiv. 2024 Dec 12:2024.01.09.24301054. doi: 10.1101/2024.01.09.24301054.
3
Plasmodium vivax in Sub-Saharan Africa: An Advancing Threat to Malaria Elimination?撒哈拉以南非洲的间日疟原虫:对疟疾消除的日益严重威胁?
Am J Trop Med Hyg. 2023 Aug 28;109(3):497-498. doi: 10.4269/ajtmh.23-0523. Print 2023 Sep 6.

本文引用的文献

1
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.儿童间日疟原虫感染:隐性负担与显著挑战,一篇叙述性综述
Infect Dis Ther. 2023 Jan;12(1):33-51. doi: 10.1007/s40121-022-00713-w. Epub 2022 Nov 15.
2
In Vitro Confirmation of Artemisinin Resistance in Plasmodium falciparum from Patient Isolates, Southern Rwanda, 2019.2019 年,来自卢旺达南部患者分离株的疟原虫青蒿素耐药性的体外确认。
Emerg Infect Dis. 2022 Apr;28(4):852-855. doi: 10.3201/eid2804.212269.
3
Fasting blood glucose in a Ghanaian adult is causally affected by malaria parasite load: a mechanistic case study using convergent cross mapping.加纳成年人的空腹血糖受疟原虫负荷的因果影响:使用会聚交叉映射的机制案例研究。
Malar J. 2022 Mar 18;21(1):93. doi: 10.1186/s12936-022-04076-y.
4
Prevalence and risk of Plasmodium vivax infection among Duffy-negative individuals: a systematic review and meta-analysis.Duffy 阴性个体中间日疟原虫感染的流行率和风险:系统评价和荟萃分析。
Sci Rep. 2022 Mar 7;12(1):3998. doi: 10.1038/s41598-022-07711-5.
5
Symptomatic Infection in Rwanda.卢旺达的有症状感染
Open Forum Infect Dis. 2022 Jan 19;9(3):ofac025. doi: 10.1093/ofid/ofac025. eCollection 2022 Mar.
6
The global burden of Plasmodium vivax malaria is obscure and insidious.全球间日疟原虫疟疾负担隐晦而隐匿。
PLoS Med. 2021 Oct 7;18(10):e1003799. doi: 10.1371/journal.pmed.1003799. eCollection 2021 Oct.
7
Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across Africa.非洲无 Duffy 阴性个体感染间日疟原虫的流行病学和遗传变异对比。
Int J Infect Dis. 2021 Jul;108:63-71. doi: 10.1016/j.ijid.2021.05.009. Epub 2021 May 12.
8
Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda.卢旺达南部疟原虫 Kelch13 多态性增加。
Emerg Infect Dis. 2021 Jan;27(1):294-296. doi: 10.3201/eid2701.203527.
9
Efficient Transmission of Mixed Plasmodium falciparum/vivax Infections From Humans to Mosquitoes.高效传播疟原虫混合感染(恶性疟原虫/间日疟原虫)。
J Infect Dis. 2020 Jan 14;221(3):428-437. doi: 10.1093/infdis/jiz388.
10
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study.绘制 2000-17 年全球间日疟原虫流行状况和临床负担图:时空建模研究。
Lancet. 2019 Jul 27;394(10195):332-343. doi: 10.1016/S0140-6736(19)31096-7. Epub 2019 Jun 19.